PTPN11 and neoplasm: Figure 2B shows the predicted driver mutation E76K at the allosteric site of SHP2 between the interface of the SH2 domain and the PTP domain, and the result is in consistent with the previous report about the driven effect of SHP2-E76K in tumor progression (34).